Status:
COMPLETED
Acute Kidney Injury and Acute Kidney Disease in COVID-19
Lead Sponsor:
University of Giessen
Conditions:
Acute Kidney Injury
Corona Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagn...
Detailed Description
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavi...
Eligibility Criteria
Inclusion
- 1\) Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria
Exclusion
- Patients aged less than 18 years
- Patients with stage 4 chronic kidney disease (baseline estimated glomerular filtration rate \<30 ml/min/1.73 m2)
- Patients receiving maintenance dialysis
- Recipients of solid-organ transplantation
Key Trial Info
Start Date :
April 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04353583
Start Date
April 21 2020
End Date
February 1 2025
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Giessen and Marburg, Giessen
Giessen, Hesse, Germany, 35382